Gilead Sciences Inc.

GILD | NASDAQ

Price Alert Chart Builder DCF Calculator

$150.56

+$0.45 (+0.30%)

At close: Sep 21, 2026, 4:00 PM ET

$149

-$1.56 (-1.04%)

After-hours: Sep 21, 2026, 7:57 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	7.8B	6.96B	7.92B	7.77B	7.08B	6.67B	7.57B	7.55B	6.95B	6.69B	7.11B	7.05B	6.6B	6.35B	7.39B	7.04B	6.26B	6.59B	7.24B	7.42B	6.22B	6.42B
Cost of Revenue	1.58B	1.45B	1.62B	1.57B	1.5B	1.54B	1.58B	1.57B	1.54B	1.55B	2.09B	1.57B	1.44B	1.4B	1.4B	1.4B	1.44B	1.42B	2.63B	1.22B	1.39B	1.36B
Gross Profit	6.22B	5.52B	6.3B	6.2B	5.58B	5.13B	5.99B	5.97B	5.41B	5.13B	5.02B	5.49B	5.16B	4.95B	5.99B	5.65B	4.82B	5.17B	4.62B	6.2B	4.83B	5.06B
Operating Income	-10.39B	2.59B	2.99B	3.33B	2.47B	2.24B	2.45B	888M	2.64B	-4.32B	1.61B	2.62B	1.67B	1.71B	2.27B	2.84B	2.03B	197M	940M	3.84B	2.25B	2.89B
Interest Income	n/a	n/a	95M	88M	73M	94M	85M	52M	35M	108M	n/a	106M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-10.25B	2.58B	2.08B	3.64B	2.43B	1.65B	2.17B	956M	2.05B	-4.49B	1.65B	2.32B	1.59B	1.3B	2.03B	2.43B	1.5B	-152M	759M	3.44B	1.82B	2.26B
Net Income	-10.5B	2.02B	2.18B	3.05B	1.96B	1.32B	1.78B	1.25B	1.61B	-4.17B	1.43B	2.18B	1.05B	1.01B	1.64B	1.79B	1.14B	19M	382M	2.59B	1.52B	1.73B
Selling & General & Admin	1.92B	1.45B	1.73B	1.36B	1.37B	1.26B	1.86B	1.41B	1.38B	1.38B	1.58B	1.32B	1.85B	1.32B	2.02B	1.21B	1.36B	1.08B	1.65B	1.19B	1.35B	1.06B
Research & Development	1.76B	1.37B	1.58B	1.35B	1.49B	1.38B	1.64B	1.4B	1.35B	1.52B	1.41B	1.46B	1.41B	1.45B	-1.15B	1.15B	1.1B	3.88B	2.03B	1.1B	1.09B	1.06B
Other Expenses	12.93B	106M	n/a	170M	250M	253M	34M	2.28B	37M	6.56B	424M	90M	236M	480M	2.86B	448M	330M	8M	n/a	65M	138M	62M
Operating Expenses	16.62B	2.93B	3.31B	2.87B	3.11B	2.89B	3.54B	5.08B	2.77B	9.46B	3.41B	2.86B	3.49B	3.25B	3.73B	2.81B	2.79B	4.97B	3.68B	2.36B	2.58B	2.17B
Interest Expense	247M	240M	255M	256M	254M	260M	249M	238M	237M	254M	252M	232M	230M	230M	226M	229M	242M	238M	238M	250M	256M	257M
Selling & Marketing Expenses	n/a	898M	1.08B	829M	864M	753M	869M	968M	805M	743M	826M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	18.2B	4.37B	4.94B	4.44B	4.61B	4.43B	5.12B	6.66B	4.31B	11.01B	5.5B	4.43B	4.93B	4.65B	5.12B	4.21B	4.23B	6.39B	6.3B	3.58B	3.97B	3.53B
Income Tax Expense	242M	559M	-105M	589M	468M	334M	385M	-297M	438M	-315M	237M	146M	549M	316M	398M	646M	368M	-164M	383M	852M	300M	542M
Shares Outstanding (Basic)	1.24B	1.24B	1.24B	1.24B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B
Shares Outstanding (Diluted)	1.24B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B
EPS (Basic)	-8.45	1.63	1.76	2.46	1.57	1.06	1.43	1	1.29	-3.34	1.15	1.75	0.84	0.81	1.31	1.43	0.91	0.01	0.30	2.06	1.21	1.38
EPS (Diluted)	-8.45	1.61	1.74	2.43	1.56	1.04	1.42	1	1.29	-3.34	1.14	1.73	0.83	0.80	1.30	1.42	0.91	0.01	0.30	2.05	1.21	1.37
EBITDA	-10.01B	3.04B	3.02B	4.58B	3.37B	2.61B	3.11B	1.88B	2.98B	-3.54B	2.59B	3.23B	2.5B	2.17B	2.79B	3.19B	2.27B	611M	1.53B	4.21B	2.59B	2.99B
EBIT	-10.01B	2.35B	2.33B	3.9B	2.68B	1.91B	2.42B	1.19B	2.29B	-4.23B	1.91B	2.55B	1.82B	1.53B	2.26B	2.66B	1.75B	86M	997M	3.69B	2.07B	2.52B
Depreciation & Amortization	n/a	689M	687M	686M	691M	696M	693M	690M	694M	690M	688M	684M	681M	640M	528M	525M	525M	525M	535M	523M	519M	473M